Cargando…
The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes
The current standard of care for type 1 diabetes patients is limited to treatment of the symptoms of the disease, insulin insufficiency and its complications, not its cause. Given the autoimmune nature of type 1 diabetes, immunology is critical to understand the mechanism of disease progression, pat...
Autor principal: | Roep, Bart O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887285/ https://www.ncbi.nlm.nih.gov/pubmed/36733487 http://dx.doi.org/10.3389/fimmu.2023.1112858 |
Ejemplares similares
-
Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
por: Suwandi, Jessica S., et al.
Publicado: (2017) -
From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
por: den Hollander, Nicoline H. M., et al.
Publicado: (2022) -
Educational Interventions Need to Be Defined Precisely
por: Walsh, Kieran
Publicado: (2013) -
Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013) -
Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
por: Wang, Bingran, et al.
Publicado: (2022)